© Copyright Nostre Net
Biopharmaceutical
Excipients Market Overview By Product and Region Forecast to 2027. According
to MRFR analysis, the global The biopharmaceutical excipients market is
expected to cross USD 2.24 Billion by 2030 at a CAGR of~5.70%.
The global biopharmaceutical excipients market is driven by
several factors, such as increasing demand for oral formulations across the
globe, rising demand for customized medicines, and an increasing geriatric
population. Other factors such as increasing patients with chronic
ailmentscoupled with growing life expectancy are driving the production of
biopharmaceuticals. In addition, increasing stress, back pains, body aches, and
headaches has augmented the demand for topical type formulation, accelerating
the market growth.
The industry players focus on expanding their global
footprint by strategic partnerships, investing in some company’s stock, acquisitions,
and product launches. For instance, in February 2020, ReForm Biologics (US)
partnered with MilliporeSigma (US) to commercialize excipients used in
biotherapeutics. In August 2019, LBB Specialties (US) announced the strategic
partnership with MEGGLE (Germany)to expand its excipient distribution channel
across the US. In December 2018, Roquette (France) bought a majority stake in
excipient producer Crest Cellose (India) that enabled the company to expand its
product portfolio and presence in the Indian generic pharmaceutical market.
Furthermore, the prominent players focus on new developments, employee
satisfaction, the transformation of their research wings, and expanding their
distribution network. These factors will augment the market growth and will
increase theproduct demand in the forecast timeline.
Key Players
Some of the key players in the global biopharmaceutical
excipients market are Merck KGaA (Germany), Colorcon (BPSI Holdings Inc) (US),
BASF SE(Germany), Associated British Foods plc (UK), Signet Excipients Pvt. Ltd
(IMCD) (Netherlands), Sigachi Industries Limited (Hyderabad), Spectrum Chemical
Manufacturing Corp. (US), Roquette Frères (France), Clariant (Switzerland), DFE
Pharma (Germany), J. Rettenmaier & Söhne Gmbh + Co Kg (Germany), and Evonik
Industries AG (Germany).
Regional Analysis
North America is projected to dominate the biopharmaceutical
excipients market research report due to the growing adoption of the latest
drug manufacturing technologies, increasing chronic diseases, and expansion of
production capabilities of the industry players across the region. In addition,
highinvestments were made in the development of new excipient variants to
advance the product portfolio. Furthermore, the key players are involved in
collaborations, mergers, and R&D activities that propel market
growth.
Europe embraces the second-largest position in the biopharmaceutical
excipients market due to growing investments in the pharmaceutical sector and
increasing production capacity across the region. In addition, the region
experienced high demands for pharmaceutical products. Moreover, countries such
asGermany, Italy, the UK, France, and Spain have invested huge amounts in the
manufacturing of new vaccines.
Asia-Pacific is anticipated to be the fastest-growing
regional market over the projected timeline due to the rising investment in
pharmaceutical research and production facilities, increasing consumption of
medicines, and supportive government alliances and subsidy schemes. In
addition, the availability of highly skilled research employees and an
economical workforce is creating opportunities for the industry players.
Segmentation
The global biopharmaceutical excipients market is
categorized into product and formulation. Based on the product category, the
market has been segregated into solubilizers & surfactants/emulsifiers,
polyols and carbohydrates, and specialty excipients. The carbohydrates segment
is expected to hold a considerable share of the market in 2021. Increasing
R&D activities for the development of lipid and protein excipient-based
corona vaccines is fueling the market demand. In addition, the high demand for
carbohydrate-based medicines for the infant segment is propelling the
biopharmaceutical excipient market.
Based on formulation, the global biopharmaceutical
excipients market has been classified as oral, topical, and injectables. The
oral segmentheld the major share in 2020 due to the easy intake procedure and
availability of oral medicines throughout the hospitals and retail stores.
Additionally, the demand for oral and topical formulations is accelerating due
to the growing preference for on-the-go treatment and ambulatory treatment
services coupled with increasing cases of trypanophobia.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and
Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The Wall